MedPath

Pelvic Girdle Pain Symptom Severity in Pregnant Women With Gestational Diabetes Mellitus

Completed
Conditions
Pelvic Girdle Pain
Pregnant Women
Gestational Diabetes
Registration Number
NCT05403437
Lead Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Brief Summary

Pelvic girdle pain (PGP), which is a common musculoskeletal problem of pregnancy, and gestational diabetes mellitus (GDM), which is diagnosed at the end of the second trimester and at the beginning of the third trimester, occur in a parallel time period. The addition of hyperglycemia to the physiological changes in pregnancy stimulates a new series of cycles and contributes to inflammation, and it is predicted that the presence of GDM may trigger the pain intensity of PGP. Therefore, the aim of this study is to investigate the effect of GDM on PGP symptom severity (pain).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
155
Inclusion Criteria
  • Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have been started.
  • Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have not been started
  • Pregnant women (with PGP) who were not diagnosed with GDM in the 2nd and 3rd trimesters
Exclusion Criteria
  • Pre-pregnancy Diabetes Mellitus
  • Presence of an orthopedic or neurological problem that may cause musculoskeletal disorders and deviations from normal biomechanical alignment
  • Presence of connective tissue disease
  • Definition of chronic low back-pelvic region pain (lasting for more than 3 months and pain severity >4 according to VAS) before pregnancy
  • History of spine, pelvis, or lower extremity surgery or fracture in the past 6 months
  • History of pelvic fracture

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determining of painful areasBaseline (Current)

Marking painful areas on the body chart

Evaluation of painBaseline (Current)

Pain will be evaluated with Visual Analog Scale (VAS). The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).

Application of PGP diagnostic testsBaseline

Pelvic Girdle Pain diagnostic tests will be applied. No score defined for test.

Evaluation of PGP severityBaseline

The severity of the pain that occurs in positive tests will be evaluated with VAS. The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).

Secondary Outcome Measures
NameTimeMethod
Evaluation of Body WeightBaseline

Measuring of the Body Weight

Pelvic Girdle QuestionnaireBaseline

Activity limitation will be evaluated Pelvic Girdle Questionnaire

Evaluation of Body Mass Index (BMI)Baseline

BMI (kg/m2) will be calculated as person's weight in kilograms divided by the square of height in meters.

Trial Locations

Locations (1)

İstanbul Medeniyet University

🇹🇷

İstanbul, Turkey

İstanbul Medeniyet University
🇹🇷İstanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.